10.1099/13500872-142-2-411 Microbiology 95 SchwechheimerS
Foundational Characterisation The synthesis and initial characterisation of Melanotan 1 by Hadley and Dorr at the University of Arizona established it as a potent, stable MC1R agonist with substantially enhanced in vivo bioactivity compared to native -MSH, and confirmed its capacity to stimulate melanogenesis in pre-clinical models
Category 2 Sugary Foods and Refined Carbohydrates Sugary and refined-carb foods work against GLP-1 medications on multiple fronts: they spike blood glucose (which the medication is trying to smooth), they provide calories without satiety, and in many patients they trigger the dumping syndrome-like response of nausea, sweating, and dizziness
Flu-Like Symptoms on GLP-1: Causes, Duration and Management Many patients starting GLP-1 receptor agonists for type 2 diabetes or weight management report experiencing flu-like symptoms during the initial weeks of treatment
Embarazo o convulsiones, supervisin